Domestic new drugs fly with business abilities of large pharmaceutical companies

Increasing domestic new drugs’ prescriptions through the business abilities of large pharmaceutical companies, the joint promotion trend among domestic companies has been settled.

According to the industry on the 15^th, ‘Godex(Celltrion),’ an intestinal drug which has been jointly sold with Hanmi Pharm since the last January, recorded KRW 26.5 billion prescriptions(UBIST) increased by 17% year-...